- Home
- TCRX vs DSP Comparison
TCRX vs DSP Comparison
Compare TCRX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- DSP
- Stock Information
- Founded
- TCRX 2018
- DSP 1999
- Country
- TCRX United States
- DSP United States
- Employees
- TCRX N/A
- DSP N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- TCRX Health Care
- DSP Technology
- Exchange
- TCRX Nasdaq
- DSP Nasdaq
- Market Cap
- TCRX 140.7M
- DSP 148.7M
- IPO Year
- TCRX 2021
- DSP 2021
- Fundamental
- Price
- TCRX $1.92
- DSP $8.56
- Analyst Decision
- TCRX Strong Buy
- DSP Strong Buy
- Analyst Count
- TCRX 5
- DSP 10
- Target Price
- TCRX $9.40
- DSP $19.85
- AVG Volume (30 Days)
- TCRX 648.1K
- DSP 265.6K
- Earning Date
- TCRX 11-07-2025
- DSP 11-10-2025
- Dividend Yield
- TCRX N/A
- DSP N/A
- EPS Growth
- TCRX N/A
- DSP N/A
- EPS
- TCRX N/A
- DSP 0.13
- Revenue
- TCRX $6,961,000.00
- DSP $318,471,000.00
- Revenue This Year
- TCRX $255.18
- DSP $16.39
- Revenue Next Year
- TCRX N/A
- DSP $14.89
- P/E Ratio
- TCRX N/A
- DSP $64.06
- Revenue Growth
- TCRX N/A
- DSP 30.92
- 52 Week Low
- TCRX $1.02
- DSP $8.11
- 52 Week High
- TCRX $6.23
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- TCRX 41.52
- DSP 44.41
- Support Level
- TCRX $2.23
- DSP $8.97
- Resistance Level
- TCRX $2.43
- DSP $9.50
- Average True Range (ATR)
- TCRX 0.19
- DSP 0.41
- MACD
- TCRX -0.04
- DSP 0.10
- Stochastic Oscillator
- TCRX 1.52
- DSP 32.37
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.